Clinical Trial Update: Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA [Phase 2]

View source ↗

Summary

A Phase II study evaluating HR18034 for adductor canal block to manage postoperative pain after total knee arthroplasty was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• HR18034

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Postoperative Pain Management in Total Knee Arthroplasty | Phase 2 | Status: TERMINATED